<?xml version="1.0" encoding="UTF-8"?>
<p>A study by Guan et al. showed that patients with severe disease were more likely to have an underlying coexisting illness compared to those with non-severe disease (38.7 vs. 21%) (
 <xref rid="B59" ref-type="bibr">59</xref>). Another study done in Wuhan, China showed that among 191 patients with COVID-19, hypertension (30%) was the most commonly reported comorbidity followed by diabetes (19%), coronary heart disease (8%), and chronic obstructive lung disease (3%) (
 <xref rid="B73" ref-type="bibr">73</xref>). According to data from the CDC in the US, among 7,162 patients with reported medical problems, diabetes mellitus (10.9%), chronic lung disease (9.2%), and cardiovascular disease (9.0%) were the most commonly reported comorbidities. Immunocompromising conditions (3.7%) and chronic kidney disease (3%) were also reported (
 <xref rid="B86" ref-type="bibr">86</xref>). In a case series study in New York including 5,700 patients with COVID-19 infection, the most common comorbidities in hospitalized patients were hypertension (56.6%), obesity (41.7%), and diabetes (33.8%) (
 <xref rid="B61" ref-type="bibr">61</xref>). Obesity was found to be risk factor for intubation in a retrospective cohort study of 124 patients with SARS-CoV-2 infection. Of the patients who were intubated, 47.6% had a body mass index (BMI) &gt; 30 kg/m
 <sup>2</sup> and 28.2% had a BMI &gt; 35 kg/m
 <sup>2</sup> (
 <xref rid="B87" ref-type="bibr">87</xref>).
</p>
